"Esophagogastric Junction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.
| Descriptor ID |
D004943
|
| MeSH Number(s) |
A03.556.875.500.414 A03.556.875.875.330
|
| Concept/Terms |
Esophagogastric Junction- Esophagogastric Junction
- Junction, Esophagogastric
- Gastroesophageal Junction
- Gastroesophageal Junctions
- Junction, Gastroesophageal
- Junctions, Gastroesophageal
|
Below are MeSH descriptors whose meaning is more general than "Esophagogastric Junction".
Below are MeSH descriptors whose meaning is more specific than "Esophagogastric Junction".
This graph shows the total number of publications written about "Esophagogastric Junction" by people in this website by year, and whether "Esophagogastric Junction" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2017 | 9 | 3 | 12 |
| 2018 | 5 | 0 | 5 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Esophagogastric Junction" by people in Profiles.
-
COVID-19 Pneumonia on Post-Operative Day 2 after Esophagectomy: Performing Esophago-Gastric Junction Cancer Surgery during the SARS-Cov-2 Second Wave. Curr Oncol. 2021 Mar 27; 28(2):1348-1353.
-
The Impact of the COVID-19 Pandemic on Barrett's Esophagus and Esophagogastric Cancer. Gastroenterology. 2021 05; 160(6):2169-2171.e1.
-
Esophagogastric junction function and gastric pressure profile after minigastric bypass compared with Billroth II. Surg Obes Relat Dis. 2019 Apr; 15(4):567-574.
-
A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: Accurate review of management and perspectives. Crit Rev Oncol Hematol. 2018 Dec; 132:161-168.
-
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer. J Clin Oncol. 2018 10 01; 36(28):2836-2844.
-
A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer. Eur J Cancer. 2018 09; 100:17-26.
-
Different lymph node staging systems for patients with adenocarcinoma of esophagogastric junction. Curr Med Res Opin. 2018 06; 34(6):963-970.
-
Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis. PLoS One. 2018; 13(1):e0189294.
-
Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry. Strahlenther Onkol. 2018 02; 194(2):125-135.
-
Clonality analysis of synchronous gastro-oesophageal junction carcinoma and distal gastric cancer by whole-exome sequencing. J Pathol. 2017 10; 243(2):165-175.